Trial Profile
A Short Term Double blind Randomised Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2008
Price :
$35
*
At a glance
- Drugs Pindolol (Primary) ; Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 26 Dec 2007 Status changed from recruiting to discontinued.
- 26 Nov 2005 New trial record.